Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» transthyretin amyloidosis with cardiomyopathy
transthyretin amyloidosis with cardiomyopathy
Alnylam’s Onpattro succeeds in open-label ATTR cardiomyopathy extension
Alnylam’s Onpattro succeeds in open-label ATTR cardiomyopathy extension
Clinical Trials Arena
Alnylam Pharmaceuticals
Onpattro
clinical trials
transthyretin amyloidosis with cardiomyopathy
Flag link:
Alnylam details anticipated results from heart disease drug trial
Alnylam details anticipated results from heart disease drug trial
BioPharma Dive
Alnylam
clinical trials
Onpattro
transthyretin amyloidosis with cardiomyopathy
Flag link: